EC Number | Cloned (Comment) | Organism |
---|---|---|
2.4.1.65 | expression in COS cells | Homo sapiens |
2.4.1.152 | expression in COS cells | Homo sapiens |
EC Number | Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|---|
2.4.1.152 | membrane | type II membrane protein, membrane-bound form in trans cistermae of Golgi | Homo sapiens | 16020 | - |
EC Number | Molecular Weight [Da] | Molecular Weight Maximum [Da] | Comment | Organism |
---|---|---|---|---|
2.4.1.152 | 43008 | - |
1 * 43008, calculation from nucleotide sequence | Homo sapiens |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
2.4.1.65 | Homo sapiens | - |
- |
- |
2.4.1.152 | Homo sapiens | Q11128 | - |
- |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
2.4.1.152 | leukocyte | - |
Homo sapiens | - |
2.4.1.152 | peripheral blood | - |
Homo sapiens | - |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
2.4.1.65 | GDP-L-fucose + 2'-fucosyllactose | 254% of the activity with Galbeta(1,4)GlcNAc | Homo sapiens | GDP + ? | - |
? | |
2.4.1.65 | GDP-L-fucose + alpha(2,3)-sialyllactosamine | 56% of the activity with Galbeta(1,4)GlcNAc | Homo sapiens | GDP + ? | - |
? | |
2.4.1.65 | GDP-L-fucose + Galbeta(1,3)GlcNAc | 420% of the activity with Galbeta(1,4)GlcNAc | Homo sapiens | GDP + Galbeta(1,3)(Fucalpha(1,4))GlcNAc | - |
? | |
2.4.1.65 | GDP-L-fucose + Galbeta(1,4)Glc | 145% of the activity with Galbeta(1,4)GlcNAc | Homo sapiens | GDP + Galbeta(1,4)(Fucalpha(1,3))Glc | - |
? | |
2.4.1.152 | GDP-L-fucose + 2'-fucosyllactose | 42% of the activity with Galbeta(1,4)GlcNAc | Homo sapiens | GDP + ? | - |
? | |
2.4.1.152 | GDP-L-fucose + alpha(2,3)sialyllactosamine | - |
Homo sapiens | GDP + ? | - |
? | |
2.4.1.152 | GDP-L-fucose + Fucalpha(1,2)Galbeta(1,4)Glc | - |
Homo sapiens | GDP + Fucalpha(1,2)Galbeta(1,4)(Fucalpha(1,3))Glc | - |
? | |
2.4.1.152 | GDP-L-fucose + Galbeta(1,3)GlcNAc | i.e. lacto-N-biose I, 10% of the activity with Galbeta(1,4)GlcNAc | Homo sapiens | GDP + ? | - |
? | |
2.4.1.152 | GDP-L-fucose + Galbeta(1,4)GlcNAc | - |
Homo sapiens | GDP + Galbeta(1,4)(Fucalpha(1,3))GlcNAc | - |
? | |
2.4.1.152 | GDP-L-fucose + Galbeta(1,4)GlcNAc | i.e. N-acetyllactosamine | Homo sapiens | GDP + Galbeta(1,4)(Fucalpha(1,3))GlcNAc | - |
? | |
2.4.1.152 | GDP-L-fucose + lacto-N-biose I | - |
Homo sapiens | GDP + ? | - |
? | |
2.4.1.152 | GDP-L-fucose + lactose | 11% of the activity with Galbeta(1,4)GlcNAc | Homo sapiens | GDP + ? | - |
? |
EC Number | Subunits | Comment | Organism |
---|---|---|---|
2.4.1.152 | monomer | 1 * 43008, calculation from nucleotide sequence | Homo sapiens |